SK23898A3 - Zwitterionic forms of trovafloxacin - Google Patents
Zwitterionic forms of trovafloxacin Download PDFInfo
- Publication number
- SK23898A3 SK23898A3 SK238-98A SK23898A SK23898A3 SK 23898 A3 SK23898 A3 SK 23898A3 SK 23898 A SK23898 A SK 23898A SK 23898 A3 SK23898 A3 SK 23898A3
- Authority
- SK
- Slovakia
- Prior art keywords
- trovafloxacin
- hygroscopic
- crystalline form
- zwitterionic
- polymorphic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Physical Water Treatments (AREA)
- Processing Of Solid Wastes (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US297595P | 1995-08-29 | 1995-08-29 | |
| PCT/IB1996/000756 WO1997007800A1 (en) | 1995-08-29 | 1996-07-29 | Zwitterionic forms of trovafloxacin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK23898A3 true SK23898A3 (en) | 1999-05-07 |
Family
ID=21703460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK238-98A SK23898A3 (en) | 1995-08-29 | 1996-07-29 | Zwitterionic forms of trovafloxacin |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0850060A1 (ru) |
| JP (1) | JP3188476B2 (ru) |
| KR (1) | KR100343909B1 (ru) |
| CN (1) | CN1190889A (ru) |
| AP (1) | AP636A (ru) |
| AR (1) | AR003985A1 (ru) |
| AU (1) | AU704115B2 (ru) |
| BR (1) | BR9609998A (ru) |
| CA (1) | CA2229786C (ru) |
| CO (1) | CO4480739A1 (ru) |
| CZ (1) | CZ56698A3 (ru) |
| DZ (1) | DZ2087A1 (ru) |
| GT (1) | GT199600072A (ru) |
| HR (1) | HRP960395B1 (ru) |
| HU (1) | HUP9900170A3 (ru) |
| IL (1) | IL122651A (ru) |
| MA (1) | MA23966A1 (ru) |
| MY (1) | MY113874A (ru) |
| NO (1) | NO309814B1 (ru) |
| NZ (1) | NZ312199A (ru) |
| OA (1) | OA10669A (ru) |
| PE (1) | PE12598A1 (ru) |
| PL (1) | PL325170A1 (ru) |
| RU (1) | RU2144921C1 (ru) |
| SK (1) | SK23898A3 (ru) |
| TN (1) | TNSN96109A1 (ru) |
| TR (1) | TR199800339T1 (ru) |
| WO (1) | WO1997007800A1 (ru) |
| YU (1) | YU48396A (ru) |
| ZA (1) | ZA967282B (ru) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HN1998000106A (es) | 1997-08-01 | 1999-01-08 | Pfizer Prod Inc | Composiciones parenterales de alatroflaxacino |
| US7019142B2 (en) | 1998-01-16 | 2006-03-28 | Pfizer Inc. | Process for preparing naphthyridones and intermediates |
| PA8466701A1 (es) | 1998-01-21 | 2000-09-29 | Pfizer Prod Inc | Comprimido de mesilato de trovafloxacino |
| US6114531A (en) * | 1998-07-28 | 2000-09-05 | Pfizer Inc. | Process for preparing quinolone and naphthyridone carboxylic acids |
| HN1999000141A (es) * | 1998-09-03 | 2000-06-19 | Pfizer Prod Inc | Procedimiento para preparar sales de trovafloxacina de adicion de acidos. |
| US6239141B1 (en) | 1999-06-04 | 2001-05-29 | Pfizer Inc. | Trovafloxacin oral suspensions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164402A (en) * | 1989-08-16 | 1992-11-17 | Pfizer Inc | Azabicyclo quinolone and naphthyridinone carboxylic acids |
-
1996
- 1996-07-29 PL PL96325170A patent/PL325170A1/xx unknown
- 1996-07-29 WO PCT/IB1996/000756 patent/WO1997007800A1/en not_active Application Discontinuation
- 1996-07-29 AU AU63676/96A patent/AU704115B2/en not_active Ceased
- 1996-07-29 TR TR1998/00339T patent/TR199800339T1/xx unknown
- 1996-07-29 CA CA002229786A patent/CA2229786C/en not_active Expired - Fee Related
- 1996-07-29 IL IL12265196A patent/IL122651A/xx not_active IP Right Cessation
- 1996-07-29 CZ CZ98566A patent/CZ56698A3/cs unknown
- 1996-07-29 SK SK238-98A patent/SK23898A3/sk unknown
- 1996-07-29 BR BR9609998A patent/BR9609998A/pt unknown
- 1996-07-29 KR KR10-1998-0701468A patent/KR100343909B1/ko not_active IP Right Cessation
- 1996-07-29 EP EP96923020A patent/EP0850060A1/en not_active Withdrawn
- 1996-07-29 NZ NZ312199A patent/NZ312199A/xx unknown
- 1996-07-29 RU RU98103873/04A patent/RU2144921C1/ru not_active IP Right Cessation
- 1996-07-29 CN CN96195624A patent/CN1190889A/zh active Pending
- 1996-07-29 JP JP50343697A patent/JP3188476B2/ja not_active Expired - Fee Related
- 1996-07-29 HU HU9900170A patent/HUP9900170A3/hu unknown
- 1996-08-23 GT GT199600072A patent/GT199600072A/es unknown
- 1996-08-26 AR ARP960104121A patent/AR003985A1/es unknown
- 1996-08-26 PE PE1996000633A patent/PE12598A1/es not_active Application Discontinuation
- 1996-08-28 ZA ZA9607282A patent/ZA967282B/xx unknown
- 1996-08-28 MY MYPI96003579A patent/MY113874A/en unknown
- 1996-08-28 MA MA24344A patent/MA23966A1/fr unknown
- 1996-08-28 TN TNTNSN96109A patent/TNSN96109A1/fr unknown
- 1996-08-28 DZ DZ960131A patent/DZ2087A1/fr active
- 1996-08-28 YU YU48396A patent/YU48396A/sh unknown
- 1996-08-29 CO CO96046149A patent/CO4480739A1/es unknown
- 1996-08-29 AP APAP/P/1996/000853A patent/AP636A/en active
- 1996-08-29 HR HR960395A patent/HRP960395B1/xx not_active IP Right Cessation
-
1998
- 1998-02-27 NO NO980862A patent/NO309814B1/no not_active Application Discontinuation
- 1998-02-27 OA OA9800026A patent/OA10669A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20010281A2 (en) | New crystalline form of omeprazole | |
| PL190869B1 (pl) | Sól sodowa omeprazolu, sposób jej wytwarzania, środek farmaceutyczny i zastosowanie soli sodowej omeprazolu | |
| US5763454A (en) | Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt | |
| SK10372001A3 (sk) | Draselná soľ (S)-omeprazolu | |
| EP0579681B1 (en) | Crystalline tiagabine hydrochloride monohydrate, its preparation and use | |
| SK23898A3 (en) | Zwitterionic forms of trovafloxacin | |
| JPH06504541A (ja) | ４−アミノ−３−アシルキノリン誘導体の塩およびその胃酸分泌抑制剤としての使用 | |
| US6066647A (en) | Zwitterionic forms of trovafloxacin | |
| SK281980B6 (sk) | Kryštallický (+)l-hydrogenvínan, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie | |
| EP0584588A1 (en) | Anti-ulcer composition containing imidazole derivative | |
| KR100274736B1 (ko) | 6-엔-(엘-에이엘에이-엘-에이엘에이)-트로바플록사신 전구약물의 폴리모프 | |
| EP1314726A1 (en) | Novel ester or amide derivatives | |
| MXPA98001664A (en) | Zwitterionic forms of trovafloxacin, procedure for its preparation, compositions that contain them and use of the mis | |
| AP788A (en) | Novel crystal form of anhydrous 7-(1a, 5a, 6a)-6-Amino-3-Azabicyclo(3.1.0) hex-3-YI)-6-Fluoro-1-(2,4- Difluorophenyl)-1,4-Dihydro-4-Oxo-1, 8-Naphthyridine-3-Carboxylic Acid, Methanesulfonic acid salt. | |
| KR20200068667A (ko) | 고체 형태의 스테모스피로닌 및 이의 염 | |
| KR20110033999A (ko) | 세로토닌 활성을 가진 화합물, 이의 제조 방법 및 이를 포함하는 약학적 조성물 | |
| SI21064A2 (sl) | Amidni derivat amlodipina |